首页> 外文期刊>Clinical nuclear medicine >FDG PET/CT in a patient with spontaneous remission of methotrexate-associated lymphoproliferative disorders after interruption of methotrexate.
【24h】

FDG PET/CT in a patient with spontaneous remission of methotrexate-associated lymphoproliferative disorders after interruption of methotrexate.

机译:甲氨蝶呤中断后自发缓解甲氨蝶呤相关的淋巴增生性疾病的患者的FDG PET / CT。

获取原文
获取原文并翻译 | 示例
           

摘要

We report a case that fluorodeoxyglucose positron emission tomography (FDG PET)/computed tomography (CT) depicted systemically multiple lesions of methotrexate (MTX)-associated lymphoproliferative disorders. A 70-year-old man receiving MTX for rheumatoid arthritis complained of neck swelling. FDG PET/CT revealed multiple FDG-avid lesions in lymph nodes, lungs, bones, and muscles. Lesions in bones and muscles were not detected on X-CT. Final diagnosis of cervical node was confirmed as MTX-associated lymphoproliferative disorders. FDG PET/CT performed 148 days after discontinuing MTX demonstrated complete remission.
机译:我们报告的情况下,氟脱氧葡萄糖正电子发射断层扫描(FDG PET)/计算机断层扫描(CT)全身性地描述了与甲氨蝶呤(MTX)相关的淋巴增生性疾病的多个病变。一名接受类风湿关节炎MTX治疗的70岁男子抱怨颈部肿胀。 FDG PET / CT显示淋巴结,肺,骨骼和肌肉中有多个FDG-avid病变。 X-CT未检测到骨骼和肌肉病变。最终诊断为淋巴结增生性疾病是MTX相关性淋巴结增生性疾病。停用MTX后148天进行的FDG PET / CT显示完全缓解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号